GlassScriptPhysician profile
Inessa Kramerman
NPI 1992147292
$7,976.22
in general payments reported to CMS, 2019-2025
18 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,911 · 2022: $2,036 · 2023: $1,814 · 2024: $980 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,783 · Education: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,782.76 |
| Education | $245.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,961.84 | 2021-2022 | |
| Abbvie INC. | $1,224.91 | 2021-2025 | |
| Janssen Biotech, INC. | $1,184.31 | 2021-2025 | Tremfya, Simponi Aria, Remicade |
| Novartis Pharmaceuticals Corporation | $805.37 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $554.88 | 2021-2025 | Winlevi, Ilumya |
| Incyte Corporation | $489.62 | 2021-2025 | Opzelura |
| Lilly USA, LLC | $421.32 | 2021-2022 | |
| Genzyme Corporation | $359.98 | 2021-2024 | |
| Pfizer INC. | $202.91 | 2021-2024 | |
| Ucb, INC. | $188.60 | 2021-2023 | Cimzia |
| E.R. Squibb & Sons, L.L.C. | $160.15 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $122.99 | 2024 | Zoryve |
| Leo Pharma INC. | $78.52 | 2021-2025 | Anzupgo, Adbry |
| Dermavant Sciences, INC. | $78.36 | 2023-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $67.10 | 2021-2024 | Dupixent |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $37.33 | 2024-2025 | Nemluvio |
| Epi Health, LLC | $23.27 | 2021 | |
| Journey Medical Corporation | $14.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inessa Kramerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.